MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
75.52
-2.65
-3.39%
After Hours: 75.52 0 0.00% 17:50 07/11 EDT
OPEN
77.66
PREV CLOSE
78.17
HIGH
77.80
LOW
75.24
VOLUME
660.61K
TURNOVER
--
52 WEEK HIGH
94.99
52 WEEK LOW
55.30
MARKET CAP
3.63B
P/E (TTM)
22.85
1D
5D
1M
3M
1Y
5Y
1D
Haemonetics Price Target Maintained With a $95.00/Share by Barrington Research
Dow Jones · 1d ago
Haemonetics Is Maintained at Outperform by Barrington Research
Dow Jones · 1d ago
Haemonetics Receives Buy Rating Amid Strategic Positioning and Positive Long-term Outlook
TipRanks · 1d ago
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
PR Newswire · 2d ago
Haemonetics Raised to Buy From Neutral by Citigroup
Dow Jones · 3d ago
Haemonetics Price Target Raised to $90.00/Share From $71.00 by Citigroup
Dow Jones · 3d ago
Citigroup Upgrades Haemonetics to Buy, Raises Price Target to $90
Benzinga · 3d ago
Haemonetics upgraded to Buy from Neutral at Citi
TipRanks · 3d ago
More
About HAE
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Webull offers Haemonetics Corp stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.